awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35995493-DFE7E41B-3A7F-4C49-BE9F-63FA3771FB2D
Q35995493-DFE7E41B-3A7F-4C49-BE9F-63FA3771FB2D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35995493-DFE7E41B-3A7F-4C49-BE9F-63FA3771FB2D
Phase II trial of capecitabine combined with docetaxel in previously treated patients with non-small cell lung cancer: A randomized controlled study.
P2860
Q35995493-DFE7E41B-3A7F-4C49-BE9F-63FA3771FB2D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35995493-DFE7E41B-3A7F-4C49-BE9F-63FA3771FB2D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ec48437ebebd7b2f23db2dc8cbbeef70a16e698a
P2860
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).